T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$3.17B |
| 2 |
Nike
NKE
|
+$1.94B |
| 3 |
Bank of America
BAC
|
+$1.84B |
| 4 |
FedEx
FDX
|
+$1.78B |
| 5 |
PNC Financial Services
PNC
|
+$1.61B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$4.1B |
| 2 |
Fortive
FTV
|
+$2.54B |
| 3 |
Linde
LIN
|
+$1.53B |
| 4 |
Alibaba
BABA
|
+$1.35B |
| 5 |
Willis Towers Watson
WTW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.61% |
| 2 | Healthcare | 16.74% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Financials | 11.46% |
| 5 | Communication Services | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Highwoods Properties
HIW
$3.51B
| $28.4M | ﹤0.01% |
844,780
-166,634
| -16% | -$6.14M |
|
1052
DaVita
DVA
$11.4B
| $28.4M | ﹤0.01% |
330,998
+29,166
| +10% | +$2.49M |
|
1053
LGI Homes
LGIH
$1.37B
| $28.2M | ﹤0.01% |
242,855
+235,048
| +3,011% | +$26M |
|
1054
Uber
UBER
$155B
| $28M | ﹤0.01% |
768,639
+247,302
| +47% | +$8.16M |
|
1055
CBRE Group
CBRE
$44B
| $28M | ﹤0.01% |
595,462
-56,104
| -9% | -$2.56M |
|
1056
W.W. Grainger
GWW
$62.2B
| $27.9M | ﹤0.01% |
78,282
-2,275
| -3% | -$784K |
|
1057
Lincoln Electric
LECO
$15.5B
| $27.9M | ﹤0.01% |
302,855
-1,828
| -0.6% | -$169K |
|
1058
Hercules Capital
HTGC
$3.17B
| $27.8M | ﹤0.01% |
2,403,547
-6,007
| -0.2% | -$66.8K |
|
1059
Ziff Davis
ZD
$1.92B
| $27.8M | ﹤0.01% |
461,471
-23,072
| -5% | -$1.31M |
|
|
VAR
1060
DELISTED
Varian Medical Systems, Inc.
VAR
| $27.7M | ﹤0.01% |
161,094
-7,381
| -4% | -$1.16M |
|
1061
Quest Diagnostics
DGX
$26.1B
| $27.7M | ﹤0.01% |
241,961
-10,411
| -4% | -$1.23M |
|
1062
Dover
DOV
$27.8B
| $27.6M | ﹤0.01% |
255,139
-12,813
| -5% | -$1.37M |
|
1063
Graphic Packaging
GPK
$3.51B
| $27.5M | ﹤0.01% |
1,951,102
-18,648
| -0.9% | -$264K |
|
1064
BOK Financial
BOKF
$8.85B
| $27.4M | ﹤0.01% |
532,782
-151,320
| -22% | -$8.32M |
|
1065
Main Street Capital
MAIN
$5.54B
| $27.4M | ﹤0.01% |
927,202
-1,319
| -0.1% | -$40.4K |
|
|
GNMK
1066
DELISTED
GenMark Diagnostics, Inc
GNMK
| $27.2M | ﹤0.01% |
1,912,424
-33,554
| -2% | -$513K |
|
|
HZN
1067
DELISTED
Horizon Global Corporation
HZN
| $27.1M | ﹤0.01% |
4,712,889
| – | – |
|
|
RNAM
1068
DELISTED
Avidity Biosciences
RNAM
| $27M | ﹤0.01% |
957,651
+7,251
| +0.8% | +$210K |
|
1069
American Vanguard Corp
AVD
$62.8M
| $26.9M | ﹤0.01% |
2,047,379
+16,900
| +0.8% | +$235K |
|
1070
Commault Systems
CVLT
$6.26B
| $26.6M | ﹤0.01% |
653,063
-18,826
| -3% | -$774K |
|
1071
Masco
MAS
$14.7B
| $26.5M | ﹤0.01% |
480,543
-23,573
| -5% | -$1.32M |
|
1072
Qorvo
QRVO
$8.68B
| $26.5M | ﹤0.01% |
205,278
-10,350
| -5% | -$1.28M |
|
1073
Q32 Bio
QTTB
$458M
| $26.4M | ﹤0.01% |
137,174
-7,604
| -5% | -$1.7M |
|
1074
Healthpeak Properties
DOC
$14.3B
| $26.3M | ﹤0.01% |
967,513
-38,260
| -4% | -$1.05M |
|
1075
Synchrony
SYF
$26.1B
| $26.2M | ﹤0.01% |
999,659
-768,794
| -43% | -$18.7M |
|
Similar funds
T. Rowe Price Associates's Q3 2020 Portfolio in Review
As of Q3 2020, T. Rowe Price Associates held 2,679 positions worth $864B, up 8.7% from $795B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2020 filing shows 185 new, 873 increased, 1,330 reduced and 90 closed positions. Its largest new stake was nCino: 5,133,240 shares worth $395M. The largest sale was People Inc, an estimated $4.1B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2020 buy was nCino: 5,133,240 shares worth $395M.
- T. Rowe Price Associates added most to Match Group in Q3 2020, an estimated $3.17B increase.
- T. Rowe Price Associates's biggest Q3 2020 reduction was People Inc, cutting an estimated $4.1B.
- T. Rowe Price Associates fully exited 58.com Inc in Q3 2020, selling an estimated $468M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $864B portfolio in Q3 2020.
- T. Rowe Price Associates opened 185 new positions and closed 90 in Q3 2020.
- T. Rowe Price Associates's portfolio value rose 8.7% quarter-over-quarter to $864B.
Based on T. Rowe Price Associates's 13F filing for Q3 2020, filed 16 Nov 2020.